middle.news
How Is AuMake Leveraging China’s OTC Market to Drive Growth?
6:16pm on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How Is AuMake Leveraging China’s OTC Market to Drive Growth?
6:16pm on Friday 30th of January, 2026 AEDT
Key Points
Positive operating cashflow of $316k driven by cost cutting and business rebasing
Cash receipts declined to $2.6m due to reduced working capital allocation
Successful entry into China’s OTC medicine market with higher margin prospects
Raised $1.5m from sophisticated and institutional investors to fund growth
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Aumake (ASX:AUK)
OPEN ARTICLE